The guanine nucleotide binding protein Ras is an important regulatory-switch in cell growth control, and Ras is often mutated in tumors. Its activation is achieved by the exchange of bound GDP for GTP, catalyzed by Sos. Targeting of Sos to the membranes for Ras activation is mediated through the adaptor protein Grb2, which is recruited to the membranes upon growth factor stimulation. Crb2 binds the prolinerich sequences of Sos via its SH3 domains. Additional studies indicate that complex mechanisms exist for Ras regulation. It is reasoned that when these control mechanisms are lost due to mutation or inactivation of regulatory molecules, even without an intrinsic Ras mutation, cancers arise frog uncontrolled cell proliferation. Based on our preliminary studies, we propose that Dab2 is such a Ras regulator. Dab2 is a 96 kd, mitogen-responsive phosphoprotein that we have recently identified and doned. We have found that Dab2 associates in vivo and in vitro with Grb2 and competes with Sos. Additionally, we found that Dab2 exhibits growth regulatory/suppressive activity. These preliminary studies have led us to hypothesize:that Dab2 stimulates the dissociation of the Grb2/Sos complex and sequesters Grb2 from Sos. In doing so, Dab2 may negatively regulate Ras activation, therefore restrain cell growth. The relevance of Dab2 in cancer is also suggested by the finding that the expression of Dab2 is lost in many breast and ovarian carcinoma cells and tissues examined to date, but is present in normal cells and tissues. We propose to study the cellular functions and growth regulatory mechanisms of Dab2 based on our hypothesis. Specifically, we will analyze the binding of Dab2 to Grb2 and its competition with Sos (Aim 1), and the effects of Dab2 on Ras activation, cell growth and transformation (Aim 2). We will also investigate the functional sigttificance of Dab2 phosphorylation (Aim 3). - Moreover, we will identify additional proteins that physically interact with Dab2 (Aim 4) in order to understand further its function and regulation. These mechanistic studies of Dab2 will enhance our understanding of its role in cell growth regulation and the possible involvement in breast and ovary tumorigenicity.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
7R01CA075389-04
Application #
6172918
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Spalholz, Barbara A
Project Start
1997-07-20
Project End
2002-06-30
Budget Start
2000-09-22
Budget End
2001-06-30
Support Year
4
Fiscal Year
2000
Total Cost
$263,886
Indirect Cost
Name
Institute for Cancer Research
Department
Type
DUNS #
872612445
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Moore, Robert; Tao, Wensi; Meng, Yue et al. (2014) Cell adhesion and sorting in embryoid bodies derived from N- or E-cadherin deficient murine embryonic stem cells. Biol Open 3:121-8
Tao, Wensi; Moore, Robert; Smith, Elizabeth R et al. (2014) Hormonal induction and roles of Disabled-2 in lactation and involution. PLoS One 9:e110737
Moore, Robert; Tao, Wensi; Smith, Elizabeth R et al. (2014) The primitive endoderm segregates from the epiblast in ?1 integrin-deficient early mouse embryos. Mol Cell Biol 34:560-72
Moore, Robert; Cai, Kathy Qi; Tao, Wensi et al. (2013) Differential requirement for Dab2 in the development of embryonic and extra-embryonic tissues. BMC Dev Biol 13:39
Heiber, Joshua F; Xu, Xiang-Xi; Barber, Glen N (2011) Potential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer. Chin J Cancer 30:805-14
Smith, Elizabeth R; Zhang, Xiao-Ying; Capo-Chichi, Callinice D et al. (2011) Increased expression of Syne1/nesprin-1 facilitates nuclear envelope structure changes in embryonic stem cell differentiation. Dev Dyn 240:2245-55
Capo-chichi, Callinice D; Yeasky, Toni M; Heiber, Joshua F et al. (2010) Explicit targeting of transformed cells by VSV in ovarian epithelial tumor-bearing Wv mouse models. Gynecol Oncol 116:269-75
Smith, Elizabeth R; Cai, Kathy Qi; Smedberg, Jennifer L et al. (2010) Nuclear entry of activated MAPK is restricted in primary ovarian and mammary epithelial cells. PLoS One 5:e9295
Cai, Kathy Qi; Caslini, Corrado; Capo-chichi, Callinice D et al. (2009) Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epithelia. PLoS One 4:e6454
Yang, Dong-Hua; Smith, Elizabeth R; Cai, Kathy Qi et al. (2009) C-Fos elimination compensates for disabled-2 requirement in mouse extraembryonic endoderm development. Dev Dyn 238:514-23

Showing the most recent 10 out of 41 publications